Cite
HARVARD Citation
Watanabe, T. et al. (2019). Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease‐modifying antirheumatic drugs. International journal of rheumatic diseases. pp. 574-582. [Online].